ASX:MSBBiotechs
Mesoblast (ASX:MSB) Valuation Check As Leadership Changes And Debt Refinancing Reset Expectations
Mesoblast (ASX:MSB) is back in focus after a cluster of late December and early January announcements, including new board leadership, fresh credit arrangements with an existing director, and sizable shelf registrations in both ordinary shares and ADSs.
See our latest analysis for Mesoblast.
The recent board reshuffle, fresh credit facility and large shelf registrations appear to have caught the market’s eye, with a 1-day share price return of 4.07% and a 7-day share price return of 10.83%...